Anna Cordeiro

700 total citations
22 papers, 426 citations indexed

About

Anna Cordeiro is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Anna Cordeiro has authored 22 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Hematology. Recurrent topics in Anna Cordeiro's work include Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (5 papers). Anna Cordeiro is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (5 papers). Anna Cordeiro collaborates with scholars based in Spain, Canada and United States. Anna Cordeiro's co-authors include Mariano Monzó, Alfons Navarro, Laureano Molins, Núria Viñolas, Ramón M. Marrades, José Ramírez, Rut Tejero, Marc Ruíz-Martínez, Joan J. Castellano and Sandra Santasusagna and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Anna Cordeiro

22 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Cordeiro Spain 8 367 320 42 32 25 22 426
Zachary Faber United States 6 234 0.6× 167 0.5× 41 1.0× 59 1.8× 37 1.5× 9 305
Paula M. Godoy United States 4 404 1.1× 212 0.7× 123 2.9× 29 0.9× 16 0.6× 7 469
Laura M. Urbanski United States 6 461 1.3× 157 0.5× 14 0.3× 49 1.5× 18 0.7× 10 538
Shuheng Wu China 6 258 0.7× 192 0.6× 19 0.5× 33 1.0× 6 0.2× 8 295
Doron Tolomeo Italy 8 180 0.5× 148 0.5× 32 0.8× 24 0.8× 24 1.0× 17 248
Maxim Pilyugin Switzerland 10 351 1.0× 96 0.3× 29 0.7× 68 2.1× 22 0.9× 16 413
Gergana Bounova Netherlands 7 307 0.8× 95 0.3× 29 0.7× 80 2.5× 46 1.8× 7 390
Reem K. Shahin Egypt 11 291 0.8× 310 1.0× 18 0.4× 57 1.8× 25 1.0× 14 412
Nicole M. Sayles United States 3 199 0.5× 113 0.4× 24 0.6× 62 1.9× 20 0.8× 3 306

Countries citing papers authored by Anna Cordeiro

Since Specialization
Citations

This map shows the geographic impact of Anna Cordeiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Cordeiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Cordeiro more than expected).

Fields of papers citing papers by Anna Cordeiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Cordeiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Cordeiro. The network helps show where Anna Cordeiro may publish in the future.

Co-authorship network of co-authors of Anna Cordeiro

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Cordeiro. A scholar is included among the top collaborators of Anna Cordeiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Cordeiro. Anna Cordeiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cordeiro, Anna, Kitipong Uaesoontrachoon, Weijiang Wu, et al.. (2025). The effect of IL-1β inhibitor canakinumab (Ilaris®) on IL-6 production in human skeletal muscle cells. PLoS ONE. 20(3). e0316110–e0316110. 2 indexed citations
2.
Prykhozhij, Sergey V., Anna Cordeiro, Kevin Ban, et al.. (2024). Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafish. Leukemia. 38(10). 2115–2126. 1 indexed citations
3.
Prykhozhij, Sergey V., Kevin Ban, Anna Cordeiro, et al.. (2023). Loss of calpain3b in Zebrafish, a Model of Limb-Girdle Muscular Dystrophy, Increases Susceptibility to Muscle Defects Due to Elevated Muscle Activity. Genes. 14(2). 492–492. 6 indexed citations
5.
Prykhozhij, Sergey V., et al.. (2021). Zebrafish Models Provide Novel Insights into the Disease Biology of Parn-Mutant Dyskeratosis Congenita and DNAJC21-Mutant Shwachman-Diamond Syndrome. Blood. 138(Supplement 1). 1110–1110. 2 indexed citations
6.
Prykhozhij, Sergey V., et al.. (2020). Genome Editing in Zebrafish Using High-Fidelity Cas9 Nucleases: Choosing the Right Nuclease for the Task. Methods in molecular biology. 2115. 385–405. 7 indexed citations
7.
Cordeiro, Anna, et al.. (2019). Characterizing Dyskeratosis Congenita Caused By Parn Mutations in the Zebrafish. Blood. 134(Supplement_1). 3744–3744. 1 indexed citations
8.
Cordeiro, Anna, Mariano Monzó, & Alfons Navarro. (2017). Non-Coding RNAs in Hodgkin Lymphoma. International Journal of Molecular Sciences. 18(6). 1154–1154. 14 indexed citations
9.
Castellano, Joan J., Alfons Navarro, Núria Viñolas, et al.. (2016). LincRNA-p21 Impacts Prognosis in Resected Non–Small Cell Lung Cancer Patients through Angiogenesis Regulation. Journal of Thoracic Oncology. 11(12). 2173–2182. 74 indexed citations
10.
Caritg, Oriol, Alfons Navarro, Isabel Moreno, et al.. (2016). Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker. Clinical Colorectal Cancer. 15(4). e175–e182. 38 indexed citations
11.
Cordeiro, Anna, Alfons Navarro, Anna Gayà, et al.. (2016). PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma. Oncotarget. 7(29). 46002–46013. 39 indexed citations
12.
Navarro, Alfons, Tania Díaz, Anna Cordeiro, et al.. (2015). Epigenetic regulation of microRNA expression in Hodgkin lymphoma. Leukemia & lymphoma. 56(9). 2683–2689. 13 indexed citations
14.
Viñolas, Núria, Alfons Navarro, Ramón M. Marrades, et al.. (2015). piRNA-651 as a prognostic marker in surgically resected non-small-cell lung cancer.. Journal of Clinical Oncology. 33(15_suppl). 11043–11043. 2 indexed citations
15.
Moisés, Jorge, Alfons Navarro, Rut Tejero, et al.. (2015). PIWI proteins as prognostic markers in non small cell lung cancer. PA4238–PA4238. 1 indexed citations
16.
Navarro, Alfons, Rut Tejero, Núria Viñolas, et al.. (2015). The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer. Oncotarget. 6(31). 31544–31556. 41 indexed citations
17.
Tejero, Rut, Alfons Navarro, Marc Campayo, et al.. (2014). miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma. PLoS ONE. 9(7). e101899–e101899. 114 indexed citations
18.
Navarro, Alfons, Anna Cordeiro, Anna Gayà, et al.. (2014). Piwirna-651 Expression Influences Treatment Response and Impacts Survival in Classical Hodgkin Lymphoma Patients through Regulation of ABCC5. Blood. 124(21). 134–134. 2 indexed citations
19.
Díaz‐Beyá, Marina, Alfons Navarro, Salut Brunet, et al.. (2014). The LincRNA HOTAIRM1, Located in the HOXA genomic Region, impacts Prognosis in Acute Myeloid Leukemia and Is Associated with a Distinctive microRNA Signature. Blood. 124(21). 1003–1003. 1 indexed citations
20.
Díaz, Tania, Rut Tejero, Isabel Moreno, et al.. (2014). Role of miR‐200 family members in survival of colorectal cancer patients treated with fluoropyrimidines. Journal of Surgical Oncology. 109(7). 676–683. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026